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Abstract
Adult hippocampal progenitor cells (AHPCs) derived from mature rats were studied in mixed co-cultures and shown not to elicit
a proliferative response from human peripheral blood mononuclear cells (PBMCs) or allogeneic spleen cells. FACS analysis revealed
low class I and no detectable class II (Ia) MHC expression by these cells. RT-PCR showed that AHPCs express the anti-inﬂam-
matory cytokine TGF-b1. AHPCs did not, however, signiﬁcantly impede the proliferation of OKT3- or PHA-stimulated PBMCs.
Taken together, these results indicate that AHPCs are non-immunogenic in vitro. This is consistent with their pattern of MHC
expression and does not require an active immunosuppressive mechanism.
 2003 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Multipotent neural progenitor cell lines have at-
tracted considerable interest recently, particularly as
sources of highly plastic donor cells for transplantation
studies (Gage, Ray, & Fisher, 1995; Renfranz, Cunn-
ingham, & McKay, 1991; Sabate et al., 1995; Snyder
et al., 1992; Young, Ray, Whiteley, Klassen, & Gage,
2000). Although neural progenitor cells frequently sur-
vive grafting to non-syngeneic hosts (Brustle et al., 1998;
Flax et al., 1998; Fricker et al., 1999; McDonald et al.,
1999; Mizumoto et al., 2001; Shatos et al., 2001; Young
et al., 2000) transplantation has generally targeted
compartments of the central nervous system (CNS)
where the phenomenon of immune privilege is known to
apply (Brevig, Holgersson, & Widner, 2000; Jiang &
Streilein, 1994; Poltorak & Freed, 1991; Schnell, Fearn,
Klassen, Schwab, & Perry, 1999; Wenkel, Streilein, &
Young, 2000). The transplant immunology of neural
progenitor cells has not been speciﬁcally investigated
and therefore it has been unclear whether these cells
exhibit decreased immunogenicity when grafted outside
of the CNS microenvironment. One reason to believe
they might comes from studies of the neuronal and glial
populations comprising the CNS parenchyma. The cells
of the mature CNS express low levels of MHC antigens
under normal conditions (Rall, 1998) and therefore
display decreased immunogenicity (Aloisi et al., 1999;
Wucherpfennig, 1994). Nevertheless, it is known that
CNS progenitors diﬀer markedly from their mature
progeny with respect to a range of molecular markers.
Whether neural progenitors share the immunological
characteristics of diﬀerentiated CNS cells is not known.
Cells capable of generating new neurons have long
been known to reside in speciﬁc sites within the adult
CNS of rodent (Altman & Das, 1965) and avian
(Goldman & Nottebohm, 1983) species. Until recently,
however, these cells had not been successfully propa-
gated ex vivo. The advent of an abundant supply of
recombinant mitogens, notably basic ﬁbroblast growth
factor (bFGF) and epidermal growth factor (EGF), has
allowed the isolation of multipotent neural progenitors
from CNS tissue via selective proliferation (Reynolds
& Weiss, 1992) or following automated cell sorting
*Corresponding author. Tel.: +1-714-516-4280; fax: +1-714-289-
4531.
E-mail address: hklassen@choc.org (H. Klassen).
0042-6989/03/$ - see front matter  2003 Elsevier Science Ltd. All rights reserved.
doi:10.1016/S0042-6989(03)00094-4
Vision Research 43 (2003) 947–956
www.elsevier.com/locate/visres
(Uchida et al., 2000). Although frequently obtained
from embryonic sources, neural progenitor cells can also
be derived from adult rodents. For example, adult hip-
pocampal progenitor cells (AHPCs) have been clonally-
derived from the dentate gyrus of rats and mice and
expanded over many generations in vitro (Gage & Ray
et al.). In the adult rodent, cells born in the subven-
tricular zone (SVZ) are known to enter the rostral mi-
gratory stream leading to the olfactory bulb where they
diﬀerentiate into resident neurons (Lois & Alvarez-
Buylla, 1993). Recently, it has been demonstrated that
proliferation-competent cells are also present in the SVZ
and dentate gyrus of aged humans (Eriksson et al.,
1998). Although the physiological signiﬁcance of such
cells in humans is not yet known, their mere existence
has generated considerable interest. In particular, neural
progenitor cells are of value for transplantation studies
directed towards neuronal repopulation of the injured or
degenerating CNS. Transplanted stem or progenitor
cells appear to be capable of migrating into and re-
populating a range of tissues, including brain (Brustle
et al., 1998) retina (Takahashi, Palmer, Takahashi, &
Gage, 1998; Young et al., 2000) spinal cord (Cao et al.,
2001; McDonald et al., 1999) and perhaps bone marrow
(Bjornson, Rietze, Reynolds, Magli, & Vescovi, 1999).
The preceding experiments included an element of
immunoprotection that may have contributed to graft
survival, namely, CNS-associated immune privilege or
systemic marrow ablation. The questions of whether
neural progenitor cells can themselves avoid immune
detection, or induce immune deviation, have not been
addressed. To assess the cell-mediated response elicited
by AHPCs in vitro, we combined these cells with pe-
ripheral blood mononuclear cells (PBMCs) or spleen
cells in one-way mixed cultures.
2. Materials and methods
2.1. Neural progenitor cell line
AHPCs were originally isolated from the brain of
adult female Fischer 344 rats, as previously described
(Gage et al., 1995). Brieﬂy, rats were anesthetized, de-
capitated and the hippocampal formation dissected free.
Dissected hippocampal tissue was incubated with en-
zymes (papain, neutral protease, DNAse) and the re-
sulting cell suspension was washed and incubated in
serum-containing medium for 24 h, followed by incu-
bation in a deﬁned medium containing high levels of
bFGF (FGF-2). From these proliferating cells, clonal
isolates were obtained and transfected via a retroviral
construct (Sah, Ray, & Gage, 1997) to express the en-
hanced jellyﬁsh green ﬂuorescent protein (eGFP)
reporter gene. Because our previous intraocular trans-
plantation study used an eGFP expressing clone (Young
et al., 2000) the same was used in the present study.
As previously described, AHPCs were grown as an
adherent monolayer in tissue culture ﬂasks coated with
polyornithine/laminin and containing DMEM/F-12
(Omega Scientiﬁc, Tarzana, CA) supplemented with 1
mM L-glutamine (Irvine Scientiﬁc, Santa Ana, CA), N2
Supplement (Invitrogen, Carlsbad, CA) and human re-
combinant bFGF (FGF-2, Promega, Madison, WI) at
20 ng/ml. Medium was completed replaced every 2–3
days and cultures split prior to reaching conﬂuence.
AHPCs were harvested using a trypsin/EDTA solution
(Custom ATV, Irvine Scientiﬁc), washed in DMEM/F-
12, centrifuged (1000 g, 3 min), resuspended and yield
assessed using trypan blue hemocytometry. Speciﬁcally
for plating into co-cultures, AHPCs were resuspended in
AIM V media without additional growth factors.
In speciﬁc cases, AHPCs were grown under diﬀeren-
tiating conditions, as above but without added bFGF
and in the presence of 5% fetal bovine serum (FBS, Ir-
vine Scientiﬁc). In other cases, AHPCs were grown
under MHC antigen-inducing conditions consisting of
standard proliferation medium supplemented with re-
combinant rat IFN-c (100 ng/ml, R&D Systems, Min-
neapolis, MN). After 4 days of treatment, IFN-c was
withdrawn via complete change to fresh standard pro-
liferation medium.
2.2. Human peripheral blood mononuclear cells
Between 50–100 ml peripheral venous blood was
drawn, per experiment, from a human volunteer (42 yr
old male; 51 yr old female) and collected in heparinized
tubes. Mononuclear cells were isolated by centrifugation
in Ficoll-Paque (Pharmacia, Peapack, NJ), washed in
HBSS (Invitrogen, Carlsbad, CA) and resuspended in
AIM V medium (Invitrogen).
2.3. Rat spleen cells
Spleens were dissected from adult female rats (syn-
geneic¼Fischer 344, allogeneic¼ Sprague Dawley)
after sacriﬁce via CO2 atmosphere. Spleens were minced
and extruded through a small pore ﬁlter to separate
cells. Resulting cell suspension was treated similarly to
PBMCs, but without Ficoll-Paque.
2.4. Mitomycin C treatment
The resuspended cells, both AHPCs and PBMCs,
were divided into treatment groups prior to being plated
to culture wells. Cells to be treated (AHPCs, PMBCs, or
spleen cells) were incubated in mitomycin C (Sigma) 25
lg/ml at 37 C in the dark for 20 min, then washed in
fresh media 3 with centrifugation and recounted.
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2.5. Mixed co-cultures
Both mitomycin-treated and untreated AHPCs were
diluted to 5 105 cells/ml in AIM V medium and ali-
quoted into wells on 96 well plates (Greiner, Fricken-
hausen, Germany) at 100 ll/well. PBMCs and spleen
cells were diluted to 3 106 cells/ml before being plated
at 100 ll/well. After plating was complete, those wells
containing only a single cell type received an additional
100 ll of AIM V such that all wells contained 200 ll
ﬁnal volume. In speciﬁc experiments, FBS was included
in all wells at a concentration of 5%. Co-cultures were
organized into eight distinct well types representing ev-
ery solitary or paired permutation of AHPC and
PBMC, treatment group included (e.g., Fig. 1). To
provide a statistical base, each data point (well type)
represented 6, or more, individual wells. Subsets of co-
culture plates were frozen on day 2 or 4 for cytokine
analysis.
2.6. Control co-cultures
As a positive control to demonstrate the ability of
human PBMCs to proliferate in the presence of rat tis-
sue, mixed co-cultures with rat spleen cells (Sprague-
Dawley) were performed. As a negative control to
demonstrate a lack of response to AHPCs by syngeneic
eﬀector cells, mixed co-cultures with rat spleen cells
(Fischer 344) were also carried out.
2.7. Cytokine detection
Subset of co-culture plates were frozen on day 2 or
4 for cytokine analysis. These plates were later
thawed and supernatants and cell lysates processed for
ELISA for human IFN-c or IL-4 (Biosource, Camarillo,
CA). The working range was approximately 10–10,000
pg/ml.
2.8. Direct mitogenic stimulation of PBMCs
In one experiment, PBMCs were cultured in the
presence of reagents known to provide antigen-inde-
pendent stimulation of lymphocyte proliferation. Either
OKT3 cell-conditioned supernatant or PHA (Bacto-
Phytohemagglutinin P, 50 ll of 1% rehydrated, Difco
Laboratories, Detroit, MI) were added to a subset of
wells on 96 well plates containing either PBMCs, AH-
PCs, or both, prepared as described previously. Wells
were radio-labeled on day 1 or 3 and harvested 1 day
later (day 2 or 4).
2.9. Mitogenic stimulation of AHPCs by PBMC-condi-
tioned medium
To investigate the stimulatory eﬀect of human leu-
kocytes on rat neural progenitor cells, AHPCs were
cultured without supplemental bFGF in medium sup-
plemented with supernatant conditioned by PBMCs.
Cells were grown on 96 well plates in 200 ll Aim V
medium. After 5 days, cell-free supernatants were har-
vested from PBMC wells and transferred to freshly
plated AHPCs as aliquots of 7.5, 15, or 75 ll. Wells were
labeled with [3H]TdR on day 1, harvested on day 5, and
processed for scintillometry.
2.10. Scintillometry
Co-culture plates not used for cytokine analysis were
labeled with 0.5 lCi [3H]TdR (6.7 Ci/mM, Amersham)
on either day 5 or day 8 and frozen one day later. After
thawing, all labeled wells were scraped to assure sus-
pension of organic material and harvested onto glass
microﬁber ﬁlters (Whatman, Fairﬁeld, NJ) using a Cell
Harvester Model M-24V (Brandel, Rockville, MD).
Filters were placed into vials that were then ﬁlled with 2
ml of Biosafe II (RPI) and [3H]TdR activity counted
using a Beckman LS 1800 Scintillation Counter (Brea,
0
200
400
600
800
1000
1200
1400
1600
1 2 3 4 5 6 7               8
cp
m Donor 1
Donor 2
1  rAHPC
2  rAHPC + hPBMC
3  rAHPC + hPBMCm
4  hPBMC
5  rAHPCm
6  rAHPCm + hPBMCm
7  rAHPCm + hPBMC
8  hPBMCm
Co - culture combination
Fig. 1. Proliferation study of Fischer 344 rat AHPCs and human
PBMCs in mixed co-cultures, with comparison between diﬀerent
PBMC donors. Note the lack of response for co-culture combination
7, indicating that hPBMCs do not proliferate in response to mitomy-
cin-treated rAHPCs. In contrast, combinations 2 and 3 show prolif-
eration of rAHPCs in response to treated or untreated hPBMCs. The
co-culture proﬁle shown here was highly reproducible and was not
dependent on PBMC donor. Shown are mean and SEM of pooled data
from two experiments, each with triplicate determinations at each
position for each donor. [3H]TdR was added 24 h prior to harvest on
day 6. The suﬃx m indicates cells treated with mitomycin C.
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CA). Mean cpm of replicate samples (6 or greater) was
determined.
2.11. Statistical analysis
Scintillation data from mixed co-culture experiments
were initially analyzed using the Kruskal–Wallis test to
detect the presence of a signiﬁcant result, followed by
pair-wise analysis of relevant data subsets using the
Wilcoxon (Mann–Whitney) test.
2.12. Flow cytometry
AHPCs or rat spleen cells were harvested as described
above and resuspended in PBS as a single cell suspen-
sion at 107 cells/ml. Cells were then transferred in 100 ll
aliquots to individual round-bottom 12 75 mm poly-
styrene centrifuge tubes for speciﬁc labeling. Multipa-
rameter cytometry was performed on FACS Vantage
(Becton Dickinson, San Jose, CA) incorporating a
Macintosh G3 computer (Apple, Cupertino, CA) run-
ning proprietary software.
To examine MHC antigens, the primary antibodies
used were puriﬁed IgG1 mouse anti-rat monoclonals
(Serotec, Kidlington, UK) used at 5 lg/100 ll. OX-18
was used to label MHC class I through binding to the
RT-1A monomorphic determinant, OX-6 was used to
label MHC class II through binding to a monomorphic
determinant of the I-A antigen. Mouse IgG1, j (MOPC-
21, Sigma, St. Louis, MO) was used as isotype control (5
lg/100 ll), phycoerythrin (PE)-conjugated F(ab)2 frag-
ment of sheep anti-mouse IgG (Sigma) was used as
secondary (5 lg into residual volume after decanting).
To test for the presence of Fas Ligand (CD95L) on
AHPCs, a biotin-conjugated hamster anti-mouse mono-
clonal primary with known cross-reactivity to rat
FasL (PharMingen, San Diego, CA) was used at 5 lg/
100 ll, followed by Cy-Chrome streptavidin secondary
(PharMingen) 0.06 lg/106 cells.
2.13. RT–PCR
Total RNA was isolated with Trizol Reagent (Invi-
trogen, Carlsbad, CA) according to manufacturers in-
structions. Two micrograms of RNA were reverse
transcribed into cDNA using the First-Strand cDNA
Synthesis Kit (Pharmacia). The cDNA was then used
for multiplex PCR using CytoXpress Quantitative PCR
Detection Kit (BioSource). The rat Th1/Th2 Switch
Cytokine and Rat Inﬂammatory Cytokine Set 1 were
used. A sample consisting of 20 lg of PCR reaction
product was then analyzed by gel electrophoresis and
visualized by ethidium bromide (EtBr) staining.
3. Results
3.1. AHPCs proliferate in mixed co-cultures, PBMCs do
not
Recognition of MHC disparate cells by lymphocytes
leads to their proliferation and generation of cytotoxic T
cells (TC) with subsequent graft rejection. To examine
the immunogenicity of neural stem cells, we used a
line AHPCs to challenge co-cultured human PBMCs
in vitro. Cells were either used untreated or pre-treated
with mitomycin C to block proliferation. Cultures were
maintained for a pre-determined number of days and
[3H]TdR was added 24 h prior to harvest.
Mixed co-cultures harvested at day 6 consistently
showed signiﬁcant diﬀerences in [3H]TdR uptake be-
tween combinatorial wells, indicating non-uniformity of
proliferative responses (Kruskal–Wallis, P > 0:0001)
(Fig. 1). Further analysis (Wilcoxon Rank Sum) con-
ﬁrmed the basis of this non-uniformity to be increased
proliferation in wells containing untreated AHPCs in
combination with PBMCs, regardless of whether the
latter were treated or not. This indicated that prolifer-
ation of AHPCs, and not PBMCs, was responsible for
the increased [3H]TdR uptake seen. The requirement for
PBMCs suggested that these cells exert a mitogenic eﬀect
on neural progenitors.
Conversely, mitomycin-treated AHPCs did not elicit
a proliferative response from either untreated PBMCs.
These results suggest that AHPCs either do not provide
non-syngeneic mononuclear cells with an immunogenic
stimulus or actively impede PBMC proliferation fol-
lowing immunogenic stimulation. Co-culture ﬁnd-
ings were reproducible using unrelated PBMC donors
(Fig. 1).
3.2. Lack of PBMC proliferation extends to a range of
co-culture conditions
To further delineate the lack of mononuclear cell
response to AHPCs, additional experiments were per-
formed. Harvesting of co-cultures at multiple time
points from 2 to 7 days showed that the absence of
PBMC proliferation was a general phenomenon and not
speciﬁc to the 6 day time point (Fig. 2). Similar results
were obtained when AHPCs were co-cultured with al-
logeneic spleen cells instead of xenogeneic PBMCs (Fig.
2).
As a positive control for responsiveness to rat im-
munogens, human PBMCs were challenged with rat
spleen cells. Mitomycin-treated xenogeneic spleen cells
generated a proliferative response in co-cultured
PMBCs (Fig. 2). As a negative control, Fischer 344 rat
spleen cells were challenged with AHPCs. No prolifer-
ative response to the syngeneic progenitors was seen
(Fig. 2). Similar to the mitogenic inﬂuence of human
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PBMCs, sygeneic rat spleen cells exerted a trophic eﬀect
on AHPCs (Wilcoxon Rank Sum, P ¼ 0:0039).
To investigate the possibility of a late response
(Murray, Nelson, Rayat, Elliott, & Korbutt, 1999),
AHPCs and PBMCs were co-cultured for 9 days. Re-
sults at this time point were also consistent with the lack
of an immunogenic response (Fig. 2). The moderate el-
evation in [3H]TdR uptake by co-cultures of mitomycin-
treated AHPCs and untreated PBMCs (Fig. 2) was
signiﬁcantly less than the marked elevation seen with
positive controls (Wilcoxon Rank Sum, P ¼ 0:0001).
An established means of promoting the diﬀerentia-
tion of hippocampal progenitors is exposing them to
serum (Ray, Peterson, Schinstine, & Gage, 1993). To
avoid this, experiments up to this point were performed
using serum-free conditions. However, because AHPCs
express mature neuronal markers following transplan-
tation (Young et al., 2000), it was of interest to know
whether the immunogenicity of AHPCs is inﬂuenced by
diﬀerentiation. Initial studies conﬁrmed widespread ex-
pression of MAPs and of GFAP by AHPCs after 5 days
incubation in vitro in FBS-containing media. Mixed co-
cultures of AHPCs and PBMCs in FBS were harvested
on day 6 or day 9 (Fig. 2). The presence of serum had a
mitogenic eﬀect on untreated AHPCs. Treated AHPCs,
however, were not associated with proliferation of
co-cultured PBMCs at the 6 day time point. At the
later 9 day time point [3H]TdR uptake was moder-
ately elevated, similar to results obtained at 9 days
without FBS and again signiﬁcantly less than positive
controls.
3.3. Cytokine production in co-cultures
The production of speciﬁc cytokine proﬁles has been
associated with diﬀerent types of immune response. As
part of our evaluation of whether AHPCs stimulate
xenogeneic PBMCs, mixed co-cultures were assayed for
the production of selected cytokines. Particular atten-
tion was given to IFN-c, an important indicator of a
Th1-type lymphoproliferative response (Fig. 3). Levels
of hIFN-c were not elevated beyond background levels
in wells containing PBMCs, either alone or co-cultured
with AHPCs, nor was there any cross-reactivity in wells
containing AHPCs alone. In contrast, high levels of
IFN-c were seen in wells containing OKT3- or PHA-
stimulated PBMCs. Similarly, ELISA data for IL-4, a
cytokine indicative of a Th2-type response, did not
shown elevation beyond background levels in wells
containing PBMCs or AHPCs, either alone or in com-
bination (all less than 5 pg/ml).
3.4. Expression of immune-related surface molecules by
AHPCs
One means of decreasing immunogenicity without the
need for active inhibition of lymphocytes is through
decreased expression of transplantation antigens, par-
ticularly molecules of the major histocompatibility
complex. Flow cytometry was used to evaluate the ex-
pression of both class I and class II (I-a) rat MHC
molecules (Fig. 4). Class I MHC was detected on AH-
PCs, although baseline expression of this antigen was
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Fig. 2. Summary of co-culture data. Filled circles connected by solid
line illustrate the inability of rAHPCs to induce hPBMC proliferation
across a range of time points. Similar results were obtained from co-
cultures containing FBS (ﬁlled triangles, broken line) as well as from
allogeneic co-cultures using Sprague Dawley rat spleen cells instead of
hPBMCs (ﬁlled square). Positive control veriﬁes proliferation of
hPBMCs in response to Fischer 344 rat spleen cells syngeneic to
rAHPCs (open diamond). Negative control shows no response of
syngeneic spleen cells to rAHPCs (open square). In each case, [3H]TdR
was added 24 h prior to harvest. Mean, SEM.
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Fig. 3. Stimulation of IFN-c production by PBMCs. Cultured
hPBMCs do not produce appreciable (>10 pg/ml) IFN-c unless stim-
ulated to do so, as is seen here with the addition of OKT3 cell-con-
ditioned medium or PHA. The presence of mitomycin-treated rAHPCs
does not stimulate IFN-c production by hPBMCs in co-culture, sup-
porting the lack of a Th1-type cytokine response. Data for PBMC and
mitomycin-treated AHPC controls were equivalent at days 2 and 4
(data shown is from day 2, unless otherwise indicated). Measured by
ELISA against hIFN-c.
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low compared to expression following stimulation of
with IFN-c (Fig. 5). No class II expression was detected
at baseline. Both class I and class II antigens were
strongly expressed by Fischer 344 spleen cells used as a
positive control.
To further evaluate the eﬀect of diﬀerentiation on
factors potentially involved in regulating immunoge-
nicity, AHPCs were cultured in FBS and evaluated for
expression of MHC antigens after 6 days and 12 days.
Expression of MHC antigens was not increased by this
treatment at either time point (data not shown). Low
level expression of class I was again present, although
appearing to diminish with time of treatment. Class II
was not expressed at either time point.
Fas Ligand (CD95 Ligand) is an important immuno-
regulatory molecule with the ability to protect cells by
inducing apoptosis in lymphocytes. Flow cytometric
analysis did not detect the presence of FasL antigen on
the surface of cultured AHPCs (Fig. 4), although this
antigen was readily conﬁrmed on the surface of mono-
nuclear cells used as positive controls. This ﬁnding is
consistent with the inability of AHPCs to inhibit lym-
phocyte proliferation under the conditions used in this
study.
While unstimulated AHPCs expressed low levels of
MHC class I, the addition of IFN-c to cultured AHPCs
resulted in marked up-regulation of this antigen by
treatment day 4 (Fig. 5). Subsequent removal of IFN-c
resulted in progressive decreases of class I antigen ex-
pression, returning to baseline levels within 9 days of
withdrawal (Fig. 5). Treatment of AHPCs with IFN-c
resulted in low, but detectable, expression of MHC class
II (data not shown).
3.5. Cytokine production by AHPCs
Using rat-speciﬁc primers, RT-PCR was used to
further investigate cytokine expression by AHPCs. Ev-
idence was obtained for expression of TGF-b1 by the
neural progenitor cells (Fig. 6). As part of this analysis,
additional evidence was obtained indicating little or no
baseline expression of IFN-c, IL-2, IL-4, or IL-10 by
these cells.
3.6. AHPCs do not inhibit PBMC proliferation
One potential explanation for the absence of PBMC
proliferation in response to xenogeneic AHPCs is that
Fig. 4. Cultured AHPCs were examined for expression of MHC molecules and Fas Ligand (FasL) by ﬂow cytometry. Low level class I expression
was evident whereas labeling for class II (Ia) and FasL was similar to isotype controls. Bold line¼ antigen, ﬁne broken line¼ isotype.
Fig. 5. Dynamic regulation of MHC class I expression by rat IFN-c.
Flow cytometric analysis shows marked induction of class I antigen
after 4 days of treatment (peak at far right) as compared to baseline
(solid peak) or isotype control (peak at far left). Withdrawal of IFN-c
resulted in progressive loss of class I (middle peaks) back to baseline
levels.
Fig. 6. RT-PCR performed on cultured AHPCs was positive for TGF-
b1 gene expression ()lane¼negative control, +lane¼positive control).
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the neural progenitor cells actively inhibit lympho-
cyte proliferation. To examine this possibility, ex-
periments were performed under conditions in which
lymphocyte proliferation was stimulated. The eﬀect of
combining AHPCs with proliferating PBMCs was
evaluated at 2 day and 4 day time points. PBMCs ex-
hibited marked proliferation in response to both OKT3
cell-conditioned supernatant and PHA, however, the
presence of co-cultured AHPCs did not eﬀect PBMC
proliferation induced by either mitogen at either time
point (Fig. 7).
3.7. PBMC-conditioned medium promotes proliferation of
AHPCs
Because initial co-culture experiments indicated that
PBMCs (and spleen cells) provide a proliferative stim-
ulus to AHPCs, an additional experiment was per-
formed to determine whether this eﬀect could be
reproduced using PBMC-conditioned supernatants
alone. Cultured AHPCs were supplemented with 3.6, 7,
or 27% PBMC-conditioned media by volume. [3H]TdR
was added on day 1 and samples were harvested on day
5 (Fig. 8). Increasing concentration of conditioned
media was associated with increased [3H]TdR uptake by
AHPCs. This response was dose-dependent, consistent
with the presence of a soluble factor (positive linear
trend, P ¼ 0:009).
4. Discussion
This study shows that a clonally-derived neural pro-
genitor cell line exhibits non-immunogenic behavior
when co-cultured with xenogeneic mononuclear leuko-
cytes. The mechanism underlying this behavior does not
necessitate active suppression of T cell proliferation,
but rather, appears to result from evasion of immune
recognition associated with baseline down-regulation
of MHC antigen expression. Neural progenitor cells
therefore appear to share at least some of the immu-
nological characteristics of their progeny, the neurons
and glia of the CNS. These ﬁndings have relevance for
developmental biology as well as for work in neural
stem cell transplantation.
It is well established that cell-mediated immunity is
the major eﬀector in transplant rejection. This process is
initiated when host CD4+ T cells recognize foreign class
II MHC molecules on the donor cells. Activated CD4+
T cells then provide help to host CD8+ T cells which in
turn recognize the donor cells by way of foreign class I
antigens and destroy them. Within this context, the
absence of class II MHC expression by AHPCs, as
shown in this study, would tend to protect them from
immunological attack via elimination of the initiating
stimulus, thereby providing an explanation for the lack
of proliferation by co-cultured xenogeneic PBMCs seen
here.
Another way in which CD4+ T cells can mediate the
destruction of foreign cells is by activating macrophages
Fig. 7. PBMC stimulation study. To investigate whether AHPCs exert
an inhibitory eﬀect on PBMC proliferation, mitomycin-treated AHPCs
were co-cultured with PBMCs in the presence of OKT3-conditioned
supernatant or PHA. Both mitogens induced PBMC proliferation at
both the 2 and 4 day time points. The addition of AHPCs did not
impede this proliferation at either time point, for either mitogen.
[3H]TdR added 24 h prior to harvest.
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Fig. 8. Growth factor eﬀect. Untreated AHPCs were cultured for 5
days in the presence of cell-free PBMC-conditioned supernatant, ad-
ded at three diﬀerent concentrations. Proliferation in the presence of
conditioned supernatant was dose-dependent (positive linear trend,
P ¼ 0:009). [3H]TdR was added on day 1. Mean, SEM.
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through the release of lymphokines. Again, this mech-
anism is dependent upon the recognition of foreign class
II antigen by CD4+ T cells. Such a pathway does not
appear to be activated under the in vitro conditions used
here, given both the lack of class II expression by AH-
PCs and the absence of elevated IFN-c in co-culture
supernatants.
In addition to the direct rejection pathway, an indi-
rect pathway has been described (Sayegh & Carpenter,
1996). This mechanism does not require the expression
of class II MHC molecules by the foreign cells, but ra-
ther, the presence of free foreign antigen. These antigens
are in turn presented to host CD4+ T cells in the context
of class II MHC by host APCs, followed by induction of
cytotoxic activity against the donor cells. Whereas a
high proportion of lymphocytes respond to foreign class
II MHC antigen directly without the need for inclusion
of an additional foreign peptide fragment, the indirect
pathway requires speciﬁc recognition of the foreign an-
tigen being presented. The absence of PBMC prolifera-
tion in mixed co-cultures indicates that this indirect
pathway was not evoked under the conditions used here.
The speciﬁc recognition of rat antigens by human
PBMCs would be unlikely in co-cultures because of the
limited diversity of lymphocytes, and thus speciﬁc TCR
idiotypes, within a given well. Such recognition might be
possible in vivo, depending in part on individual history
of exposure.
One speciﬁc antigen that deserves comment is the
MHC class I molecule. It is clear from our ﬂow cyto-
metric data that AHPCs do express class I antigen, al-
beit at relatively low levels. This result is consistent with
the generally low expression of MHC class I molecules
by astrocytes and other resident cells of the CNS. It is
equally clear that expression of class I antigen did not
elicit proliferation of xenogeneic or allogeneic immune
eﬀector cells in vitro, likely for reasons cited above.
Nevertheless, as we have shown, expression of class I
and to some extent class II can be up-regulated by IFN-
c. The substantial increase in class I expression seen
following exposure to this cytokine is consistent with the
appropriate regulation of transplantation antigens by
AHPCs, as is the return to baseline levels following
withdrawal. This dynamic response to a pro-inﬂamma-
tory mediator may in part explain the activation of
neural progenitor cells by CNS injury, a crucial and
poorly understood aspect of stem cell-mediated repair.
Another speciﬁc antigen of particular interest is GFP.
Again, we saw no evidence of immune eﬀector cell
proliferation, indicating that expression of the enhanced
version of this jellyﬁsh protein by AHPCs did not result
in antigen-mediated activation in vitro. Given the fre-
quent use of this molecular labeling technique in trans-
plantation studies, the immunological consequences of
GFP expression are worthy of comprehensive in vivo
characterization.
There are a number of additional pathways that can
result in the immunological destruction of grafted cells.
These include the recognition of minor transplantation
antigens, antibody-associated rejection, as well as the
activation of NK and cd T cells. None of these various
mechanisms would appear to be relevant to the results
presented here. NK cells could potentially pose a threat
to cells in which viral infection is used to insert a foreign
gene. The theoretical relevance of cd T cells lies in their
ability to destroy cells in an MHC-unrestricted manner.
Because cd T cells appear to be localized to the external
epithelial surfaces of the body, it seems unlikely that this
interaction would pertain to foreseeable neural trans-
plant scenarios.
A major consideration in all stem and progenitor cell
transplantation is the generation of diﬀerentiated prog-
eny following transfer to the host. The antigenic prop-
erties of these progeny may diﬀer from those of their less
diﬀerentiated parents, and their immunogenic properties
may diﬀer as well. Exposure of AHPCs to FBS is suﬃ-
cient to induce the expression of neuronal, and espe-
cially glial, markers (Gage et al., 1995; Ray et al., 1993),
yet insuﬃcient to evoke a Th1 response from co-cul-
tured xenogeneic PBMCs. Neither was there an associ-
ated increase in MHC expression by serum-treated
AHPCs. This is consistent with the decreased MHC
expression characteristic of mature CNS cells under
normal conditions (Rall, 1998).
In addition to avoiding detection via decreased MHC
antigen expression, AHPCs might actively suppress T
cells, either through the secretion of factors or the ex-
pression of surface molecules. For instance, this study
shows that AHPCs express TGF-b1, a factor with
known lymphosuppressive activity. Interestingly, no
inhibition of mitogenically-induced proliferation of co-
cultured PBMCs was seen, either in the presence of anti-
CD3 activity or PHA. The signiﬁcance of TGF-b1
expression by neural progenitor cells awaits clariﬁca-
tion, but might serve an autocrine role as a suppressor of
MHC expression. The lack of FasL expression by AH-
PCs also argues against the alternative hypothesis of
neural progenitor-mediated lympholytic activity.
Technical points worthy of mention include the use of
serum- and bFGF-free conditions so as to moderate
between the opposing tendencies of diﬀerentiation and
proliferation, respectively. While not optimal for either
co-culture cell type, this compromise provided a con-
sistent baseline for comparison between experimental
conditions. Although FBS is an eﬀective diﬀerentiating
agent, there can be non-speciﬁc eﬀects, particularly at
late time points. More speciﬁc agents such as CNTF, or
retinoic acid and forskolin, might be useful to promote
the diﬀerentiation of selected cell types. A retrovirally
transfected cell line was used, largely because this same
cell line is being used in parallel in vivo work (Young
et al., 2000). Since no immunogenic response was elicited
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by transfected AHPCs, this potential complication does
not appear to have been involved here.
There are also a number of broader points of interest.
In particular, the results of this in vitro study do not rule
out the possibility that in vivo conditions could induce
more immunogenic phenotypes, either in the progenitor
cells or their progeny. For instance, pro-inﬂammatory
conditions are associated with elevated levels of IFN-c
and TNF-a and up-regulation of MHC expression by
neurons and glia (Neumann, Schmidt, Cavalie, Jenne, &
Wekerle, 1997). Traditionally grouped among the last,
microglia can more speciﬁcally described as the local
APCs of the CNS. It is now widely accepted that mi-
croglia are of bone marrow origin and migrate into the
CNS secondarily (Cuadros & Navascues, 1998). Nev-
ertheless, the possibility that such cells can in some in-
stances be of neuroepithelial origin remains diﬃcult to
rule out (Bjornson et al., 1999). This is important when
considering whether grafted NSCs have the potential to
diﬀerentiate into MHC class II-expressing ‘‘passenger’’
APCs and thereby facilitate their own rejection. In that
regard, we have grafted neural progenitor cells from
Fischer 344 rats into the diseased CNS of RCS rats and
found sustained survival of allogeneic cells without ob-
vious signs of rejection (Young et al., 2000). In that
study, AHPCs appeared to respond in a tropic manner
to the degenerative microenvironment. Analogous
ﬁndings have also been reported in other models using
NSC transplantation (Bjornson et al., 1999; Brustle
et al., 1998). Pro-inﬂammatory cytokines are obvious
candidates for such injury cues and might play a role in
directing stem cell migration and diﬀerentiation in re-
sponse to cell loss. The regional and temporal variations
in cytokine and MHC antigen expression in the devel-
oping and mature CNS suggest a complex interplay of
immunological and neural signaling (Huh et al., 2000;
Neumann et al., 1997), the full scope of which remains
to be deﬁned.
The immunological characterization of neural stem
cells is now beginning. The present study shows that a
neural progenitor line, clonally-derived from the hip-
pocampal formation of adult rats, exhibits non-immu-
nogenic behavior in vitro. One factor that appears to
contribute to this behavior is low level class I and no
detectable class II (Ia) MHC antigens. In this respect,
neural progenitors, at least those found in the hippo-
campal formation of mature rats, resemble the neurons
and glia to which they give rise. Immunologically, neural
progenitor lines therefore provide a major advantage
over neural tissue grafts in that they are free of immu-
nogenic cell types such as passenger leukocytes and en-
dothelial cells. Furthermore, neural progenitors do not
appear to diﬀerentiate into immunogenic cell types
under a range of in vitro or in vivo conditions. Addi-
tional studies are indicated to determine the extent to
which the results of this study generalize to neural
progenitor lines derived at diﬀerent developmental time
points, from diﬀerent CNS regions, and from other
mammalian species.
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